The impact of needle-exchange programs on the spread of HIV among injection drug users: A simulation study

Objective. To determine the impact of the implementation of a needle-exchange program (NEP) on the spread of human immunodeficiency virus (HIV) in an injection drug user (IDU) community. We conducted a Monte Carlo simulation study of a theoretical population of 10,000 IDUs. The population was followed monthly from 1984 to 2000. HIV was assumed to be transmitted only by needle sharing. The NEP was introduced in 1989 and evaluated over a period of 11 years. The impacts of the proportion of the population attending the NEP, the risk level of IDUs attending the NEP, the reduction in needle-sharing frequency, and the number of new needle-sharing partners acquired at the NEP on prevalence and incidence of HIV were determined. Increasing the proportion of the population who always attend the NEP and eliminating needle-sharing incidents among IDUs who always attended the NEP were the most effective ways of reducing the spread of HIV. Attracting high-risk users instead of lower risk users to the NEP also reduced the spread of HIV, but to a lesser extent. NEPs are effective at reducing the spread of HIV; even under the worst case scenario of low risk users more likely to attend the NEP, one additional partner per month as a result of attending the NEP, and poor NEP attendance, the estimated prevalence was still less than that from the scenario without an NEP. Under our model, NEPs were shown to reduce the spread of HIV significantly. Efforts should be focused on getting as many IDUs as possible to become regular NEP attenders and stop sharing needles rather than partially reducing the frequency of sharing by a larger number of IDUs.

[1]  R. Chaisson,et al.  Cocaine use and HIV infection in intravenous drug users in San Francisco. , 1989, JAMA.

[2]  E H Kaplan,et al.  Needles that kill: modeling human immunodeficiency virus transmission via shared drug injection equipment in shooting galleries. , 1989, Reviews of infectious diseases.

[3]  R Allard A mathematical model to describe the risk of infection from sharing injection equipment. , 1990, Journal of acquired immune deficiency syndromes.

[4]  D Peterson,et al.  Monte Carlo simulation of HIV infection in an intravenous drug user community. , 1990, Journal of acquired immune deficiency syndromes.

[5]  J Blatherwick,et al.  Vancouver's needle exchange program. , 1990, Canadian journal of public health = Revue canadienne de sante publique.

[6]  J. Gerberding,et al.  AIDS risk and risk reduction in the radiology department. , 1991, AJR. American journal of roentgenology.

[7]  S. J. Clark,et al.  High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection. , 1991, The New England journal of medicine.

[8]  D. D. Des Jarlais,et al.  Risk factors and HIV seropositivity among injecting drug users in Bangkok. , 1991, AIDS.

[9]  D. Ho,et al.  Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection. , 1991, The New England journal of medicine.

[10]  D. Vlahov,et al.  New evidence on intravenous cocaine use and the risk of infection with human immunodeficiency virus type 1. , 1991, American journal of epidemiology.

[11]  S. Friedman,et al.  International epidemiology of HIV and AIDS among injecting drug users. , 1992, AIDS.

[12]  C. Hartgers,et al.  Needle sharing and participation in the Amsterdam Syringe Exchange program among HIV-seronegative injecting drug users. , 1992, Public health reports.

[13]  E H Kaplan Needle exchange or needless exchange? The state of the debate. , 1992, Infectious agents and disease.

[14]  E H Kaplan,et al.  A model-based estimate of HIV infectivity via needle sharing. , 1992, Journal of acquired immune deficiency syndromes.

[15]  L. Manzon,et al.  HIV seroprevalence among street involved Canadians in Vancouver. , 1992, AIDS education and prevention : official publication of the International Society for AIDS Education.

[16]  M. Musicco,et al.  Mortality of intravenous drug users living in Milan, Italy: role of HIV‐1 infection , 1994, AIDS.

[17]  V. Guadagnino,et al.  Relevance of intravenous cocaine use in relation to prevalence of HIV, hepatitis B and C virus markers among intravenous drug abusers in southern Italy. , 1995, Journal of clinical & laboratory immunology.

[18]  S. Friedman,et al.  Regulating controversial programs for unpopular people: methadone maintenance and syringe exchange programs. , 1995, American journal of public health.

[19]  E. H. Kaplan Economic analysis of needle exchange. , 1995, AIDS.

[20]  R. Brettle,et al.  The epidemiology of HIV infection in Edinburgh related to the injecting of drugs: an historical perspective and new insight regarding the past incidence of HIV infection derived from retrospective HIV antibody testing of stored samples of serum. , 1996, The Journal of infection.

[21]  J Atkinson A simulation model of the dynamics of HIV transmission in intravenous drug users. , 1996, Computers and biomedical research, an international journal.

[22]  P. Lurie,et al.  An opportunity lost: HIV infections associated with lack of a national needle-exchange programme in the USA , 1997, The Lancet.

[23]  M. Iannelli,et al.  The HIV/AIDS epidemics among drug injectors: a study of contact structure through a mathematical model. , 1997, Mathematical biosciences.

[24]  J. Kaldor,et al.  Effectiveness of needle-exchange programmes for prevention of HIV infection , 1997, The Lancet.

[25]  G. Makulowich HIV and STD Prevention Update , 1997 .

[26]  K. Vranizan,et al.  Who uses needle exchange? A study of injection drug users in treatment in San Francisco, 1989-1990. , 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[27]  E. Franco,et al.  High rates of HIV infection among injection drug users participating in needle exchange programs in Montreal: results of a cohort study. , 1997, American journal of epidemiology.

[28]  Julio S. G. Montaner,et al.  Needle exchange is not enough: lessons from the Vancouver injecting drug use study , 1997, AIDS.

[29]  D Greenhalgh,et al.  Mathematical modelling of the spread of HIV/AIDS amongst injecting drug users. , 1997, IMA journal of mathematics applied in medicine and biology.

[30]  C. Archibald,et al.  A qualitative investigation into an HIV outbreak among injection drug users in Vancouver, British Columbia. , 1998, AIDS care.

[31]  M. Kretzschmar,et al.  Modelling the spread of HIV in social networks of injecting drug users , 1998, AIDS.

[32]  G. Makulowich Cost effectiveness of SEPs. , 1998, AIDS patient care and STDs.

[33]  M. Schechter,et al.  Factors associated with frequent needle exchange program attendance in injection drug users in Vancouver, Canada. , 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[34]  Lawrence Corey,et al.  Biological and Virologic Characteristics of Primary HIV Infection , 1998, Annals of Internal Medicine.

[35]  M. Schechter,et al.  Do needle exchange programmes increase the spread of HIV among injection drug users?: an investigation of the Vancouver outbreak. , 1999, AIDS.

[36]  L. D. Saunders,et al.  Cost effectiveness of Streetworks' needle exchange program of Edmonton. , 1999, Canadian journal of public health = Revue canadienne de sante publique.

[37]  D Burrows,et al.  HIV infection associated with drug injecting in the newly independent states, eastern Europe: the social and economic context of epidemics. , 1999, Addiction.

[38]  D. Vlahov,et al.  Prevention of HIV Infection in Street‐Recruited Injection Drug Users , 2000, Journal of acquired immune deficiency syndromes.

[39]  M. L. Laurie,et al.  Health risks and opportunities for harm reduction among injection-drug-using clients of Saskatoon's needle exchange program. , 2000, Canadian journal of public health = Revue canadienne de sante publique.

[40]  G. Ippolito,et al.  Syringe laws and pharmacy regulations are structural constraints on HIV prevention in the US. , 2000 .

[41]  D. D. Jarlais,et al.  Research, politics, and needle exchange. , 2000 .

[42]  M. L. Laurie,et al.  Health Risks and Opportunities for Harm Reduction Among Injection-drug-using Clients of Saskatoon’s Needle Exchange Program , 2000 .

[43]  S. Strathdee,et al.  Evaluating effectiveness of syringe exchange programmes: current issues and future prospects. , 2000, Social science & medicine.

[44]  C. Towe,et al.  High Street Prices of Syringes Correlate with Strict Syringe Possession Laws , 2000, The American journal of drug and alcohol abuse.

[45]  D. D. Des Jarlais Research, politics, and needle exchange. , 2000, American journal of public health.

[46]  C. Guenter,et al.  HIV Prevalence Remains Low Among Calgary’s Needle Exchange Program Participants , 2000, Canadian journal of public health = Revue canadienne de sante publique.

[47]  Scott Burris,et al.  Syringe laws and pharmacy regulations are structural constraints on HIV prevention in the US , 2000, AIDS.

[48]  F. Laufer Cost‐Effectiveness of Syringe Exchange as an HIV Prevention Strategy , 2001, Journal of acquired immune deficiency syndromes.

[49]  D. Vlahov,et al.  Needle-exchange participation, effectiveness, and policy: Syringe relay, gender, and the paradox of public health , 2001, Journal of Urban Health.

[50]  M. Schechter,et al.  Risk-taking behaviors among injecting drug users who obtain syringes from pharmacies, fixed sites, and mobile van needle exchanges , 2002, Journal of Urban Health.